BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24005067)

  • 1. [Fatty liver: frequent and not completely harmless].
    Lang C; Georgi A; Gubler C
    Praxis (Bern 1994); 2013 Sep; 102(18):1089-101. PubMed ID: 24005067
    [No Abstract]   [Full Text] [Related]  

  • 2. [Noninvasive diagnosis of fatty liver disease].
    Qu Y; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):155-7. PubMed ID: 20196962
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of alcoholic and non-alcoholic fatty liver].
    Stremmel W; Blechacz B; Herrmann T; Rost D; Mueller S
    Internist (Berl); 2001 Dec; 42(12):1641-2, 1645-50. PubMed ID: 11793603
    [No Abstract]   [Full Text] [Related]  

  • 4. [Non-alcoholic fatty liver--life of overindulgence with fatty liver].
    Füessl HS
    MMW Fortschr Med; 2005 Jun; 147(25):4-6, 8. PubMed ID: 16038330
    [No Abstract]   [Full Text] [Related]  

  • 5. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ; ; ;
    Am J Gastroenterol; 2012 Jun; 107(6):811-26. PubMed ID: 22641309
    [No Abstract]   [Full Text] [Related]  

  • 6. Alcoholic and nonalcoholic forms of fatty liver disease.
    Forgione A; Miele L; Cefalo C; Gasbarrini G; Grieco A
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):83-100. PubMed ID: 17415346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-alcoholic steatohepatitis - from NAFLD to MAFLD].
    Balmer ML; Dufour JF
    Ther Umsch; 2011 Apr; 68(4):183-8. PubMed ID: 21452138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAFLD and cardiovascular risk: direct evidence for the tale of two ages.
    Lonardo A; Loria P
    Am J Gastroenterol; 2009 Jul; 104(7):1851-2. PubMed ID: 19574981
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
    Jepsen P; Vilstrup H; Mellemkjaer L; Thulstrup AM; Olsen JH; Baron JA; Sørensen HT
    Hepatogastroenterology; 2003; 50(54):2101-4. PubMed ID: 14696473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alcohol and fatty liver].
    Böhle E; Erb W; Siede W
    Internist (Berl); 1968 Jun; 9(6):247-55. PubMed ID: 4883775
    [No Abstract]   [Full Text] [Related]  

  • 11. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Steatosis and non-alcoholic steatohepatitis].
    Marín-López ER; Marín-Rentería NM
    Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():96-7. PubMed ID: 24041073
    [No Abstract]   [Full Text] [Related]  

  • 13. Do we need a histological score to diagnose non-alcoholic steatohepatitis?
    Wong VW; Chan HL
    Aliment Pharmacol Ther; 2011 Aug; 34(4):494-5; author reply 495-6. PubMed ID: 21767281
    [No Abstract]   [Full Text] [Related]  

  • 14. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
    Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence.
    Nobili V; Pinzani M
    Alcohol Alcohol; 2011; 46(5):627-9. PubMed ID: 21697185
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations.
    Oneta CM; Dufour JF
    Swiss Med Wkly; 2002 Sep; 132(35-36):493-505. PubMed ID: 12506331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-alcoholic steato-hepatitis].
    Linhart HG
    Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final results of a long-term, clinical follow-up in fatty liver patients.
    Dam-Larsen S; Becker U; Franzmann MB; Larsen K; Christoffersen P; Bendtsen F
    Scand J Gastroenterol; 2009; 44(10):1236-43. PubMed ID: 19670076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revision and update on clinical practice guideline for liver cirrhosis.
    Suk KT; Baik SK; Yoon JH; Cheong JY; Paik YH; Lee CH; Kim YS; Lee JW; Kim DJ; Cho SW; Hwang SG; Sohn JH; Kim MY; Kim YB; Kim JG; Cho YK; Choi MS; Kim HJ; Lee HW; Kim SU; Kim JK; Choi JY; Jun DW; Tak WY; Lee BS; Jang BK; Chung WJ; Kim HS; Jang JY; Jeong SW; Kim SG; Kwon OS; Jung YK; Choe WH; Lee JS; Kim IH; Shim JJ; Cheon GJ; Bae SH; Seo YS; Choi DH; Jang SJ;
    Korean J Hepatol; 2012 Mar; 18(1):1-21. PubMed ID: 22511898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.